BRAF and differentiated thyroid carcinoma: On the other end, BRAF V600E and similar molecular alterations such as RET and NTRK rearrangement are the defining molecular markers for “conventional” papillary thyroid carcinoma, i.e., those characterized by the presence of neoplastic papillae.